SynthesisBioscience reports2020

LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.

Shubo Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.